All Stories

  1. Multidrug resistance in Helicobacter pylori: current state and future directions

    Article • Expert Review of Clinical Pharmacology, August 2019, Taylor & Francis

    Lyudmila Boyanova, Dr Rumyana D Markovska

  2. Relation between emm types and virulence gene profiles among Bulgarian Streptococcus pyogenes clinical isolates

    Article • Infectious Diseases, July 2019, Taylor & Francis

    Raina Gergova, Lena Setchanova, Dr Rumyana D Markovska

  3. First report of Enterobacter asburiae isolate, producing NDM-1 and a novel ACT-68 enzyme in Bulgaria

    Article • Infectious Diseases, June 2019, Taylor & Francis

    Dr Rumyana D Markovska, Petya Stankova, Lyudmila Boyanova, Raina Gergova

  4. Quinolone resistance mechanisms among third-generation cephalosporin resistant isolates of Enterobacter spp. in a Bulgarian university hospital

    Article • Infection and Drug Resistance, May 2019, Dove Medical Press

    Dr Rumyana D Markovska, Lyudmila Boyanova, Petya Stankova

  5. Clostridioides (Clostridium) difficile carriage in asymptomatic children since 2010: a narrative review

    Article • Biotechnology & Biotechnological Equipment, January 2019, Taylor & Francis

    Lyudmila Boyanova, Dr Rumyana D Markovska

  6. Influence of Dietary Factors onHelicobacter pyloriand CagA Seroprevalence in Bulgaria

    Article • Gastroenterology Research and Practice, January 2017, Hindawi Publishing Corporation

    Dr Rumyana D Markovska, Lyudmila Boyanova

  7. Detection of CMY-99, a Novel Acquired AmpC-Type β-Lactamase, and VIM-1 in Proteus mirabilis Isolates in Bulgaria

    Article • Antimicrobial Agents and Chemotherapy, October 2013, ASM Journals

    Dr Rumyana D Markovska

  8. First detection of the AmpC beta-lactamase ACC-1 in aKlebsiella pneumoniaeisolate in Bulgaria

    Article • Journal of Chemotherapy, October 2012, Taylor & Francis

    Dr Rumyana D Markovska